5444852025-04-012025-06-305444852025-04-012025-06-30in-capmkt:OtherExpenses1Member5444852025-04-012025-06-30

ItemsThatWillNotBeReclassifiedToProfitAndLoss1

iso4217:INRiso4217:INRxbrli:shares

544485

REGAAL

NOTLISTED

INE0MHO01029

REGAAL RESOURCES LIMITED

Main Board

Equity

2025-04-01

2026-03-31

2025-09-09

2025-09-04

INR

Millions

Quarterly

First quarter

Single segment

Manufacturing of Maize Starch and its Derivatives

2025-09-09

11:45:00

2025-09-09

14:25:00

false

Not Applicable

2025-04-01

2025-06-30

Unaudited

Standalone

2465690000

2570000

2468260000

1340280000

423510000

83850000

73380000

87190000

39420000

300010000

2347640000

120620000

16530000

13420000

29950000

90670000

-10000

90660000

410680000

1.1

1.09

1.1

1.09

1. The above unaudited financial results have been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34, Interim Financial Reporting ('Ind AS 34'), prescribed under section 133 of the Companies Act, 2013 ('the Act'), and other accounting principles generally accepted in India and is in compliance with the presentation and disclosure requirements of Regulation 33 of the Listing Regulations, including relevant circulars issued by the SEBI from time to time. 2. The company is primarily engaged in the business of manufacturing of ‘Maize starch and its derivatives’. There are no separate reporting segment under IND AS 108 “Operating Segments” notified under the companies (Indian Accounting Standard) Rules, 2015, as amended. 3. Subsequent to the Quarter ended June 30th, 2025, the Company has completed its IPO of 29,999,520 equity shares of face value Rs. 5 each at an issue price of Rs.102 per share (including a share premium of Rs. 97 per share) and as a result the equity shares of the Company were listed on National Stock Exchange of India Limited (NSE) and Bombay Stock Exchange Limited (BSE) on August 20, 2025. The issue comprised of a fresh issue of 20,587,520 equity shares aggregating to Rs.2,099.93 millions and offer for sale of 9,412,000 equity shares by selling shareholders aggregating to Rs.960.02 millions. 4. The figures of quarter ended March 31,2025 are the balancing figures between audited figures in respect of full financial year and the audited figures for interim financial statements for the nine months period ended 31st December,2024. 5. The paid-up equity share capital and basic/diluted earnings per share have been adjusted and presented to reflect the effects of the share sub-division (face value revised from Rs 10 to Rs.5) and the bonus issue undertaken during the financial year ended 31 March 2025 (i.e., subsequent to June 30, 2024), in accordance with Ind AS 33 -Earnings per Share. 6. The above results were reviewed by the Audit Committee and approved by the Board of Directors at their respective meeting held on September 09, 2025. Limited review of unaudited financial results for the quarter ended June 30, 2025 has been carried out by the Statutory Auditors, as required under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Other Expenses

300010000

Remeasurement of the defined benefit plan

-10000